Vsee Health Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 282/482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 5.00.In the medium term, the stock price is expected to trend down.
Vsee Health Inc's Score
Industry at a Glance
Industry Ranking
282 / 482
Overall Ranking
540 / 4562
Industry
Software & IT Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
5.000
Target Price
+278.79%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Vsee Health Inc Highlights
StrengthsRisks
VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 63.40% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 10.42M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 10.42M.
Overvalued
The company’s latest PE is 1.02, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 1.34M shares, increasing 6.80% quarter-over-quarter.
VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.
Ticker SymbolVSEE
CompanyVsee Health Inc
CEOAisiku (Imoigele)
Websitehttps://vsee.com/
FAQs
What is the current price of Vsee Health Inc (VSEE)?
The current price of Vsee Health Inc (VSEE) is 0.469.
What is the symbol of Vsee Health Inc?
The ticker symbol of Vsee Health Inc is VSEE.
What is the 52-week high of Vsee Health Inc?
The 52-week high of Vsee Health Inc is 2.520.
What is the 52-week low of Vsee Health Inc?
The 52-week low of Vsee Health Inc is 0.430.
What is the market capitalization of Vsee Health Inc?
The market capitalization of Vsee Health Inc is 7.99M.
What is the net income of Vsee Health Inc?
The net income of Vsee Health Inc is -57.70M.
Is Vsee Health Inc (VSEE) currently rated as Buy, Hold, or Sell?
According to analysts, Vsee Health Inc (VSEE) has an overall rating of --, with a price target of 5.000.
What is the Earnings Per Share (EPS TTM) of Vsee Health Inc (VSEE)?
The Earnings Per Share (EPS TTM) of Vsee Health Inc (VSEE) is 0.458.